Craft

Rockwell Medical

Stock Price

$4

2024-10-29

Market Capitalization

$122.9 M

2024-10-29

Revenue

$69.3 M

FY, 2025

Rockwell Medical Summary

Company Summary

Overview
Rockwell Medical is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with products and services for the treatment of iron deficiency, secondary hyperparathyroidism, and hemodialysis. It offers medical and surgical equipment, pharmaceutical products, back-office products, orthopedic products, and instruments, such as cotton balls, exam tables, diagnostic lights, tongue depressors, ECG equipment and supplies, spirometry equipment, rapid lab testing equipment and supplies, disposable items, and more. The company’s customers include physicians, obstetricians and gynecologists, pediatricians, surgeons, vocational schools, correctional complexes, state and Government agencies, occupational and industrial healthcare facilities, and other specialty practices in the United States.
Type
Public
Status
Active
Founded
1995
HQ
Wixom, MI, US | view all locations
Website
http://www.rockwellmed.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Russell H. Ellison

    Russell H. Ellison, President and Chief Executive Officer

    • Russell L. Skibsted

      Russell L. Skibsted, Executive Vice President, Chief Financial Officer and Chief Business Officer

      • Marc Hoffman

        Marc Hoffman, Chief Medical Officer

        • Ray Pratt

          Ray Pratt, Chief Development Officer

        LocationsView all

        1 location detected

        • Wixom, MI HQ

          United States

          30142 Wixom Rd

        Rockwell Medical Financials

        Summary Financials

        Revenue (Q1, 2026)
        $17.3M
        Gross profit (Q1, 2026)
        $2.9M
        Net income (Q1, 2026)
        ($1.6M)
        Cash (Q1, 2026)
        $9.6M
        EBIT (Q1, 2026)
        ($1.5M)
        Enterprise value
        $127.2M

        Footer menu